How Blockchain is Acting as a Game Changer in Pharmaceutical Industry?
What is Blockchain?
Blockchain is an open
distributed ledger, which organizes data in a series of chronologically grouped
transactions referred as blocks. It is specifically designed for supply chains
where transactions between two or more parties can be done in a verifiable and
permanent fashion that cannot be changed once recorded.
It is a disruptive technology
that will drive transformational change to the way business is done both
internally and externally. This is especially true for the supply chains. Blockchain
establishes the records in a permanent way that can be integrated with supply
chains and traceability systems.
Supply chains in Pharmaceutical industry
With the help of blockchain
technology, the data can be easily tracked across the entire supply chain at an
unimaginable speed. When pharmaceutical industry is concerned, it provides the
supply chain leaders the ability to track the pharmaceuticals from the point
they are being in the manufacturing plants to the time they are delivered to
the customer. The vulnerabilities in pharmaceutical supply chains lead to
various weak points such as decreased visibility for tracking and
authentication of the products. It allows them to trace each product or item to
its source as blockchain technology keeps solid records.
A new blockchain pilot
project is being explored by the US Food and Drug Administration in the
pharmaceutical industry and various ways in which it can be incorporated into
the pharmaceutical supply chains. For this, four organizations were selected to
be a part of this pilot project including IBM, KPMG, Merck, and Walmart. Each
organization being chosen by FDA brings technical knowledge and comprehensive
experience in implementing blockchain technology to this pilot project for the
safety, traceability and enhancement of the products.
“The ability to leverage
existing cloud infrastructure is making enterprise blockchain increasingly
affordable and adaptable, helping drug manufacturers, distributors and
dispensers meet their patient safety and supply chain integrity goals.” Arun
Ghosh, Blockchain Leader, KPMG.
The primary objectives of FDA for proposing this are:
·
To reduce the
time required to track and trace inventory
·
Help in timely
retrieval of the reliable distribution information
·
Increase the data
accuracy that is being shared among the network members
·
Help in managing
the integrity of the products in the distribution chain such as, whether the
products are kept at correct temperatures or not
This pilot project of FDA is
just one of the many initiatives, utilized to explore the application of
blockchain technology in the supply chains of life sciences industry.
Group50, a renowned supply chain blockchain consulting firm
has created a plug and play permission based blockchain solution built on an
IoT platform that is driven by smart contracts. This approach creates an
immutable chain of custody with full provenance that mimics the value add
workflow in a supply chain. While there are hundreds of uses for blockchain,
they are focused on a critical few supply chain use cases like:
·
Food
·
Aircraft
·
Automotive
·
Compliance and
Regulatory
·
Healthcare
·
Oil and Gas
·
Intellectual
Blockchain technology is
changing and evolving at a frenetic pace. It will be impossible for people in
your organization to stay abreast of those changes. Group50’s supply chain blockchain consultants have
expertise in business process design, organizational design and digital
technology, coupled with their unique plug and play technology, positions them
to be your partner in adopting and managing this transformative technology in a
way that is both scalable and sustainable.
Comments
Post a Comment